- Home
- PLBY vs LENZ Comparison
PLBY vs LENZ Comparison
Compare PLBY & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLBY | LENZ |
|---|---|---|
| Founded | 1953 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.0M | 155.5M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLBY | LENZ |
|---|---|---|
| Price | $1.22 | $4.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.00 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 741.2K | 726.4K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $120,928,000.00 | $19,088,000.00 |
| Revenue This Year | $9.17 | $50.42 |
| Revenue Next Year | $7.10 | $197.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.13 | N/A |
| 52 Week Low | $1.08 | $4.54 |
| 52 Week High | $2.75 | $50.19 |
Technical Indicators
Market Signals| Indicator | PLBY | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 49.81 | 39.39 |
| Support Level | $1.22 | N/A |
| Resistance Level | $1.30 | $6.18 |
| Average True Range (ATR) | 0.08 | 0.36 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 14.77 | 6.35 |
Price Performance
Historical ComparisonAbout PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.